[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Amphastar Pharmaceuticals Inc (AMPH) - Financial and Strategic SWOT Analysis Review

April 2021 | 55 pages | ID: A6D3C8FC607EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Amphastar Pharmaceuticals Inc (AMPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It sells insulin active pharmaceutical ingredient products. The company’s key products include enoxaparin sodium injection; cosyntropin for injection; naloxone hydrochloride (HCl) injection and phytonadione injection; lidocaine jelly; amphadase hyaluronidase injection; Primatene Mist and lidocaine jelly. Amphastar offers its products to alternate care sites, hospitals, clinics and doctors’ offices and long-term care facilities. The company markets its products through subsidiaries, specialty distributors, wholesalers and retailers in the US, the UK, France and China. Amphastar is headquartered in Rancho Cucamonga, California, the US.

Amphastar Pharmaceuticals Inc Key Recent Developments

Apr 06,2021: Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference
Mar 15,2021: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020
Mar 08,2021: Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021
Feb 26,2021: Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference
Nov 06,2020: Amphastar Pharmaceuticals reports financial results for the three months ended September 30, 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Amphastar Pharmaceuticals Inc - Key Facts
Amphastar Pharmaceuticals Inc - Key Employees
Amphastar Pharmaceuticals Inc - Key Employee Biographies
Amphastar Pharmaceuticals Inc - Major Products and Services
Amphastar Pharmaceuticals Inc - History
Amphastar Pharmaceuticals Inc - Company Statement
Amphastar Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Amphastar Pharmaceuticals Inc - Business Description
Business Segment: Active Pharmaceutical Ingredients (API)
Overview
Performance
Business Segment: Finished Pharmaceutical Products
Overview
Performance
Geographical Segment: China
Performance
Geographical Segment: France
Performance
Geographical Segment: The US
Performance
R&D Overview
Amphastar Pharmaceuticals Inc - Corporate Strategy
Amphastar Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Amphastar Pharmaceuticals Inc - Strengths
Amphastar Pharmaceuticals Inc - Weaknesses
Amphastar Pharmaceuticals Inc - Opportunities
Amphastar Pharmaceuticals Inc - Threats
Amphastar Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amphastar Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 06, 2021: Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference
Mar 15, 2021: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020
Mar 08, 2021: Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021
Feb 26, 2021: Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference
Nov 06, 2020: Amphastar Pharmaceuticals reports financial results for the three months ended September 30, 2020
Aug 06, 2020: Amphastar Pharmaceuticals reports financial results for the three months ended June 30, 2020
Jun 12, 2020: Amphastar Pharmaceuticals to present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference
May 07, 2020: Amphastar Pharmaceuticals reports financial results for the three months ended March 31, 2020
May 04, 2020: Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020
Apr 13, 2020: Amphastar Pharmaceuticals announces simplification of management structure

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Amphastar Pharmaceuticals Inc, Key Facts
Amphastar Pharmaceuticals Inc, Key Employees
Amphastar Pharmaceuticals Inc, Key Employee Biographies
Amphastar Pharmaceuticals Inc, Major Products and Services
Amphastar Pharmaceuticals Inc, History
Amphastar Pharmaceuticals Inc, Other Locations
Amphastar Pharmaceuticals Inc, Subsidiaries
Amphastar Pharmaceuticals Inc, Key Competitors
Amphastar Pharmaceuticals Inc, Ratios based on current share price
Amphastar Pharmaceuticals Inc, Annual Ratios
Amphastar Pharmaceuticals Inc, Annual Ratios (Cont...1)
Amphastar Pharmaceuticals Inc, Annual Ratios (Cont...2)
Amphastar Pharmaceuticals Inc, Interim Ratios
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amphastar Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Amphastar Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Amphastar Pharmaceuticals Inc, Ratio Charts
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications